Mehmet Altan

7.2k citations
121 papers · 2.5k indexed · h-index 24
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers 74
    • Lung Cancer Research Studies 17
    • Colorectal Cancer Treatments and Studies 15
    • CAR-T cell therapy research 13
    • Lung Cancer Treatments and Mutations 41
    • Lung Cancer Diagnosis and Treatment 15
  • Immunology top 5%
    • Immunotherapy and Immune Responses 8
    • Cancer Genomics and Diagnostics 10
  • Genetics top 10%

Mehmet Altan

114 papers receiving 2.5k citations

Peers

Mehmet Altan
Comparison fields: 5 of 88
  • Oncology 2.1k
  • Pulmonary and Respiratory Medicine 885
  • Immunology 559
  • Cancer Research 200
  • Genetics 137
Replace Hira Rizvi with:
Hira Rizvi United States
Kelly Olino United States
Sofiya Latifyan Switzerland
Rahul Ladwa Australia
Justine V. Cohen United States
Claire F. Friedman United States
Anne Cairoli Switzerland
Ryan D. Gentzler United States
Asim Amin United States
Julian A. Marin‐Acevedo United States
Mehmet Altan relative to Hira Rizvi United States Hira Rizvi's profile →
Citations per field
00.5×
Hira Rizvi · 1×
Citations per year

Countries citing papers authored by Mehmet Altan

Since Specialization
Citations

This map shows the geographic impact of Mehmet Altan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmet Altan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmet Altan more than expected).

Fields of papers citing papers by Mehmet Altan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehmet Altan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmet Altan. The network helps show where Mehmet Altan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mehmet Altan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mehmet Altan Line = papers co-authored together Mehmet Altan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20251
4 20241
5 20242
6 20245
7 20231
8 20231
9 202317
10 20236
11 202323
12 20228
13 20222
14 202119
15 20219
16 202040
17 201835
18 2017108
19 2016160
20 201428

About Mehmet Altan

Mehmet Altan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 121 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (74 papers), Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (15 papers), Colorectal Cancer Treatments and Studies (15 papers), CAR-T cell therapy research (13 papers), Cancer Genomics and Diagnostics (10 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (885 citations) and Immunology (559 citations). Mehmet Altan has collaborated with scholars based in United States, China and Greece. Frequent co-authors include David L. Rimm, Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Roy S. Herbst, Yinghong Wang, Maria Toki, Hamzah Abu‐Sbeih, Mark M. Awad, Scott Gettinger and Patricia Gaule. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026